MyFinsight
Home
Blog
About
Back
Income Statement
Edgewise Therapeutics, Inc. (EWTX)
Edgewise Therapeutics, Inc. (EWTX)
source: myfinsight.com
Total comprehensive
loss
-$57,575K
(-58.56%↓ Y/Y)
Interest income
$4,616K
(-28.93%↓ Y/Y)
Net loss
-$57,327K
(-58.73%↓ Y/Y)
Unrealized gain on
available-for-sale securities, net
-$248K
(-25.89%↓ Y/Y)
Total other income
$4,616K
(-28.93%↓ Y/Y)
Loss from operations
-$61,943K
(-45.37%↓ Y/Y)
Total operating
expenses
$61,943K
(45.37%↑ Y/Y)
Research and development
$47,548K
(41.69%↑ Y/Y)
General and
administrative
$14,395K
(59.03%↑ Y/Y)
Back